We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+12.18%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$491M
AUM Growth
+$122M
Cap. Flow
+$86.1M
Cap. Flow %
17.54%
Top 10 Hldgs %
22.8%
Holding
3,415
New
216
Increased
2,072
Reduced
599
Closed
94

Sector Composition

Rank Sector Weight
1 Technology 22.36%
2 Financials 13.02%
3 Healthcare 9.95%
4 Consumer Discretionary 8.47%
5 Industrials 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UIS icon
2701
Unisys
UIS
$217M
$599 ﹤0.01%
+122
New +$741
NAPA
2702
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$596 ﹤0.01%
64
+20
+45% +$183
TARO
2703
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$593 ﹤0.01%
14
+12
+600% +$505
THR
2704
DELISTED
Thermon Group Holdings
THR
$589 ﹤0.01%
18
-9
-33% -$264
AMPL icon
2705
Amplitude
AMPL
$1.41B
$588 ﹤0.01%
54
+30
+125% +$368
SRDX
2706
DELISTED
Surmodics
SRDX
$587 ﹤0.01%
+20
New +$638
ALCO icon
2707
Alico
ALCO
$283M
$586 ﹤0.01%
20
-1
-5% -$29
SB icon
2708
Safe Bulkers
SB
$774M
$585 ﹤0.01%
118
OSG
2709
DELISTED
Overseas Shipholding Group Inc.
OSG
$582 ﹤0.01%
91
PLRX icon
2710
Pliant Therapeutics
PLRX
$65M
$581 ﹤0.01%
39
+19
+95% +$313
OCFC icon
2711
OceanFirst Financial
OCFC
$1.91B
$574 ﹤0.01%
35
-44
-56% -$710
HDSN
2712
Hudson Technologies
HDSN
$235M
$573 ﹤0.01%
52
+49
+1,633% +$638
DMRC icon
2713
Digimarc Corp
DMRC
$178M
$571 ﹤0.01%
21
-19
-48% -$658
RKLB icon
2714
Rocket Lab Corp
RKLB
$51.8B
$571 ﹤0.01%
139
-141
-50% -$651
TRDA icon
2715
Entrada Therapeutics
TRDA
$267M
$567 ﹤0.01%
+40
New +$566
ZLAB icon
2716
Zai Lab
ZLAB
$2.62B
$561 ﹤0.01%
35
+24
+218% +$505
SIBN icon
2717
SI-BONE Inc
SIBN
$834M
$557 ﹤0.01%
+34
New +$640
TRNS icon
2718
Transcat
TRNS
$871M
$557 ﹤0.01%
5
+2
+67% +$212
FUSN
2719
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$554 ﹤0.01%
+26
New +$311
LLYVA icon
2720
Liberty Live Group Series A
LLYVA
$9.09B
$551 ﹤0.01%
+13
New +$485
NGM
2721
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$550 ﹤0.01%
346
BCRX icon
2722
BioCryst Pharmaceuticals
BCRX
$2.4B
$549 ﹤0.01%
108
+1
+0.9% +$6
SGRY icon
2723
Surgery Partners
SGRY
$2.03B
$537 ﹤0.01%
18
ULBI icon
2724
Ultralife
ULBI
$106M
$537 ﹤0.01%
61
LXU icon
2725
LSB Industries
LXU
$693M
$536 ﹤0.01%
61
-248
-80% -$1.95K

Similar funds

GAMMA Investing's Q1 2024 Portfolio in Review

As of Q1 2024, GAMMA Investing held 3,415 positions worth $491M, up 33% from $369M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

GAMMA Investing deployed $86.1M of net new capital in Q1 2024, opening 216 new positions and adding to 2,072 existing holdings. Its largest new stake was iShares Preferred and Income Securities ETF: 25,078 shares worth $808K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was BHP, an estimated $82K trimmed.

  • GAMMA Investing's largest Q1 2024 buy was iShares Preferred and Income Securities ETF: 25,078 shares worth $808K.
  • GAMMA Investing added most to Microsoft in Q1 2024, an estimated $4.04M increase.
  • GAMMA Investing's biggest Q1 2024 reduction was BHP, cutting an estimated $82K.
  • GAMMA Investing fully exited Kimco Realty in Q1 2024, selling an estimated $158K.
  • GAMMA Investing's ten largest holdings make up 23% of its $491M portfolio in Q1 2024.
  • GAMMA Investing opened 216 new positions and closed 94 in Q1 2024.
  • GAMMA Investing's portfolio value rose 33% quarter-over-quarter to $491M.

Based on GAMMA Investing's 13F filing for Q1 2024, filed 5 Apr 2024.